271 related articles for article (PubMed ID: 17006874)
21. Donepezil preserves cognition and global function in patients with severe Alzheimer disease.
Black SE; Doody R; Li H; McRae T; Jambor KM; Xu Y; Sun Y; Perdomo CA; Richardson S
Neurology; 2007 Jul; 69(5):459-69. PubMed ID: 17664405
[TBL] [Abstract][Full Text] [Related]
22. Caregiver characteristics are associated with neuropsychiatric symptoms of dementia.
Sink KM; Covinsky KE; Barnes DE; Newcomer RJ; Yaffe K
J Am Geriatr Soc; 2006 May; 54(5):796-803. PubMed ID: 16696746
[TBL] [Abstract][Full Text] [Related]
23. Treatment of behavioral and psychological symptoms of Alzheimer-type dementia with Yokukansan in clinical practice.
Hayashi Y; Ishida Y; Inoue T; Udagawa M; Takeuchi K; Yoshimuta H; Kiue K; Ninomiya Y; Kawano J; Sameshima T; Kawahara T; Goto I; Shudo K; Kurayama S; Nakamura J; Okahara K; Mitsuyama Y
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):541-5. PubMed ID: 20184936
[TBL] [Abstract][Full Text] [Related]
24. Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial.
Doody RS; Ferris SH; Salloway S; Sun Y; Goldman R; Watkins WE; Xu Y; Murthy AK
Neurology; 2009 May; 72(18):1555-61. PubMed ID: 19176895
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness of open-label donepezil treatment in patients with Alzheimer's disease discontinuing memantine monotherapy.
Sakka P; Tsolaki M; Hort J; Hager K; Soininen H; López Pousa S; Li C; Schwam E
Curr Med Res Opin; 2007 Dec; 23(12):3153-65. PubMed ID: 17988434
[TBL] [Abstract][Full Text] [Related]
26. Donepezil in the treatment of patients with Alzheimer's disease.
Tsuno N
Expert Rev Neurother; 2009 May; 9(5):591-8. PubMed ID: 19402770
[TBL] [Abstract][Full Text] [Related]
27. Predicting long-term cognitive outcome with new regression models in donepezil-treated Alzheimer patients in a naturalistic setting.
Wattmo C; Hansson O; Wallin AK; Londos E; Minthon L
Dement Geriatr Cogn Disord; 2008; 26(3):203-11. PubMed ID: 18769065
[TBL] [Abstract][Full Text] [Related]
28. Donepezil in Alzheimer's disease: eighteen month results from Southampton Memory Clinic.
Matthews HP; Korbey J; Wilkinson DG; Rowden J
Int J Geriatr Psychiatry; 2000 Aug; 15(8):713-20. PubMed ID: 10960883
[TBL] [Abstract][Full Text] [Related]
29. [Memantine for treatment of behavioural disturbances and psychotic symptoms in moderate to moderately severe Alzheimer dementia: a naturalistic study in outpatient services in Austria].
Schmidt R; Baumhackl U; Berek K; Brücke T; Kapeller P; Lechner A; Rainer M; Stögerer EM
Neuropsychiatr; 2010; 24(2):125-31. PubMed ID: 20605008
[TBL] [Abstract][Full Text] [Related]
30. Analysis of the effect of memantine in reducing the worsening of clinical symptoms in patients with moderate to severe Alzheimer's disease.
Wilkinson D; Andersen HF
Dement Geriatr Cogn Disord; 2007; 24(2):138-45. PubMed ID: 17622761
[TBL] [Abstract][Full Text] [Related]
31. Effects of donepezil on verbal memory after semantic processing in healthy older adults.
FitzGerald DB; Crucian GP; Mielke JB; Shenal BV; Burks D; Womack KB; Ghacibeh G; Drago V; Foster PS; Valenstein E; Heilman KM
Cogn Behav Neurol; 2008 Jun; 21(2):57-64. PubMed ID: 18541979
[TBL] [Abstract][Full Text] [Related]
32. A 2-year open-label study of galantamine therapy in Chinese Alzheimer's disease patients in Hong Kong.
Chu LW; Yik PY; Mok W; Chung CP
Int J Clin Pract; 2007 Mar; 61(3):403-10. PubMed ID: 17313606
[TBL] [Abstract][Full Text] [Related]
33. [Relief for caregivers. Anti-dementia drug saves costs].
MMW Fortschr Med; 2001 Oct; 143(42):64. PubMed ID: 11697297
[No Abstract] [Full Text] [Related]
34. The effect of donepezil therapy on health costs in a Medicare managed care plan.
Hill JW; Futterman R; Mastey V; Fillit H
Manag Care Interface; 2002 Mar; 15(3):63-70. PubMed ID: 11925682
[TBL] [Abstract][Full Text] [Related]
35. Effects of donepezil on activities of daily living: integrated analysis of patient data from studies in mild, moderate and severe Alzheimer's disease.
Gauthier S; Lopez OL; Waldemar G; Jones RW; Cummings J; Zhang R; Schindler R; Schwam E
Int Psychogeriatr; 2010 Sep; 22(6):973-83. PubMed ID: 20534179
[TBL] [Abstract][Full Text] [Related]
36. Results, rhetoric, and randomized trials: the case of donepezil.
Gilstad JR; Finucane TE
J Am Geriatr Soc; 2008 Aug; 56(8):1556-62. PubMed ID: 18662199
[TBL] [Abstract][Full Text] [Related]
37. Early onset effects of galantamine treatment on attention in patients with Alzheimer's disease.
Vellas B; Cunha L; Gertz HJ; De Deyn PP; Wesnes K; Hammond G; Schwalen S;
Curr Med Res Opin; 2005 Sep; 21(9):1423-9. PubMed ID: 16197661
[TBL] [Abstract][Full Text] [Related]
38. Pain with donepezil.
Kuloor CB; Puranik A
Age Ageing; 2006 Nov; 35(6):639-40. PubMed ID: 16820527
[TBL] [Abstract][Full Text] [Related]
39. Effects of donepezil on memory and cognition in multiple sclerosis.
Christodoulou C; Melville P; Scherl WF; Macallister WS; Elkins LE; Krupp LB
J Neurol Sci; 2006 Jun; 245(1-2):127-36. PubMed ID: 16626752
[TBL] [Abstract][Full Text] [Related]
40. Quality of life and cholinesterase inhibitors: a qualitative study of patients with Alzheimer's disease and their carers.
Smith B; Chur-Hansen A; Neale A; Symon J
Australas Psychiatry; 2008 Dec; 16(6):433-7. PubMed ID: 18777227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]